BACKGROUND: BRCA1/2 testing is not recommended for children, as risk reduction measures and screening are not generally recommended before 25 years old (YO). Little is known about the prevalence and predictors of parent communication to offspring and how offspring respond to this communication. METHODS: Semi-structured interviews were conducted with parents who had BRCA1/2 testing and at least 1 child <25 YO. Logistic regressions were utilized to evaluate associations with communication. Framework analysis was utilized to analyze open-ended responses. RESULTS: A total of 253 parents completed interviews (61% response rate), reporting on 505 offspring. Twenty-nine percent of parents were BRCA1/2 mutation carriers. Three hundred thirty-four (66%) offspring learned of their parent's test result. Older offspring age (P ≤ .01), offspring gender (female, P = .05), parents' negative test result (P = .03), and parents' education (high school only, P = .02) were associated with communication to offspring. The most frequently reported initial offspring responses were neutral (41%) or relief (28%). Thirteen percent of offspring were reported to experience concern or distress (11%) in response to parental communication of their test results. Distress was more frequently perceived among offspring learning of their parent's BRCA1/2 positive or variant of uncertain significance result. CONCLUSIONS: Many parents communicate their BRCA1/2 test results to young offspring. Parents' perceptions of offspring responses appear to vary by offspring age and parent test result. A better understanding of how young offspring respond to information about hereditary risk for adult cancer could provide opportunities to optimize adaptive psychosocial responses to risk information and performance of health behaviors, in adolescence and throughout an at-risk life span.
BACKGROUND:BRCA1/2 testing is not recommended for children, as risk reduction measures and screening are not generally recommended before 25 years old (YO). Little is known about the prevalence and predictors of parent communication to offspring and how offspring respond to this communication. METHODS: Semi-structured interviews were conducted with parents who had BRCA1/2 testing and at least 1 child <25 YO. Logistic regressions were utilized to evaluate associations with communication. Framework analysis was utilized to analyze open-ended responses. RESULTS: A total of 253 parents completed interviews (61% response rate), reporting on 505 offspring. Twenty-nine percent of parents were BRCA1/2 mutation carriers. Three hundred thirty-four (66%) offspring learned of their parent's test result. Older offspring age (P ≤ .01), offspring gender (female, P = .05), parents' negative test result (P = .03), and parents' education (high school only, P = .02) were associated with communication to offspring. The most frequently reported initial offspring responses were neutral (41%) or relief (28%). Thirteen percent of offspring were reported to experience concern or distress (11%) in response to parental communication of their test results. Distress was more frequently perceived among offspring learning of their parent's BRCA1/2 positive or variant of uncertain significance result. CONCLUSIONS: Many parents communicate their BRCA1/2 test results to young offspring. Parents' perceptions of offspring responses appear to vary by offspring age and parent test result. A better understanding of how young offspring respond to information about hereditary risk for adult cancer could provide opportunities to optimize adaptive psychosocial responses to risk information and performance of health behaviors, in adolescence and throughout an at-risk life span.
Authors: Angela R Bradbury; Linda Patrick-Miller; Brian Egleston; Colleen Burke Sands; Tianyu Li; Helen Schmidheiser; Maia Feigon; Comfort N Ibe; Fay J Hlubocky; Kisha Hope; Sarah Jackson; Melanie Corbman; Olufunmilayo I Olopade; Mary Daly; Christopher K Daugherty Journal: J Clin Oncol Date: 2010-06-21 Impact factor: 44.544
Authors: Angela R Bradbury; Linda Patrick-Miller; Lisa Schwartz; Brian Egleston; Colleen Burke Sands; Wendy K Chung; Gord Glendon; Jasmine A McDonald; Cynthia Moore; Paula Rauch; Lisa Tuchman; Irene L Andrulis; Saundra S Buys; Caren J Frost; Theresa H M Keegan; Julia A Knight; Mary Beth Terry; Esther M John; Mary B Daly Journal: Pediatrics Date: 2015-10-19 Impact factor: 7.124
Authors: Willem Eijzenga; Daniela E E Hahn; Neil K Aaronson; Irma Kluijt; Eveline M A Bleiker Journal: J Genet Couns Date: 2013-08-31 Impact factor: 2.537
Authors: Ruqayyah Abdul-Karim; Benjamin E Berkman; David Wendler; Annette Rid; Javed Khan; Tom Badgett; Sara Chandros Hull Journal: Pediatrics Date: 2013-02-11 Impact factor: 7.124
Authors: Diana Harris; Linda Patrick-Miller; Lisa Schwartz; John Lantos; Chris Daugherty; Mary Daly; Irene L Andrulis; Saundra S Buys; Wendy K Chung; Caren J Frost; Esther M John; Theresa H M Keegan; Julia A Knight; Mary Beth Terry; Angela R Bradbury Journal: J Adolesc Health Date: 2014-05-17 Impact factor: 5.012
Authors: Claire C Conley; Dana Ketcher; Maija Reblin; Monica L Kasting; Deborah Cragun; Jongphil Kim; Kimlin Tam Ashing; Cheryl L Knott; Chanita Hughes-Halbert; Tuya Pal; Susan T Vadaparampil Journal: J Genet Couns Date: 2020-01-07 Impact factor: 2.537
Authors: Kenneth P Tercyak; Darren Mays; Tiffani A DeMarco; Beth N Peshkin; Heiddis B Valdimarsdottir; Katherine A Schneider; Judy E Garber; Andrea Farkas Patenaude Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-07 Impact factor: 4.254
Authors: Angela R Bradbury; Linda Patrick-Miller; Lisa A Schwartz; Brian L Egleston; Dare Henry-Moss; Susan M Domchek; Mary B Daly; Lisa Tuchman; Cynthia Moore; Paula K Rauch; Rebecca Shorter; Kelsey Karpink; Colleen Burke Sands Journal: J Clin Oncol Date: 2016-08-22 Impact factor: 44.544
Authors: Angela R Bradbury; Linda Patrick-Miller; Brian L Egleston; Lisa A Schwartz; Colleen B Sands; Rebecca Shorter; Cynthia W Moore; Lisa Tuchman; Paula Rauch; Shreya Malhotra; Brianne Rowan; Stephanie Van Decker; Helen Schmidheiser; Lisa Bealin; Patrick Sicilia; Mary B Daly Journal: Breast Cancer Res Treat Date: 2012-10-14 Impact factor: 4.872